MUMBAI, India, May 30 -- Intellectual Property India has published a patent application (202517016590 A) filed by Chong Kun Dang Pharmaceutical Corp., Seoul, Republic of Korea, on Feb. 25, for 'stable antibody composition.'
Inventor(s) include Lee, Yoon Seok; Kwon, Sang Oh; Kim, Mi Gyeong; Yoon, Hee Hun; Lee, Sa Muk; and Kim, So Hyun.
The application for the patent was published on May 30, under issue no. 22/2025.
According to the abstract released by the Intellectual Property India: "The present disclosure relates to an aqueous pharmaceutical composition, a method of preparing the same, and use thereof, the aqueous pharmaceutical composition including: risankizumab or an antigen-binding fragment thereof; and a stabilizer, wherein the aqueous pharmaceutical composition does not include a polyol."
The patent application was internationally filed on Oct. 19, 2023, under International application No.PCT/KR2023/016295.
Disclaimer: Curated by HT Syndication.
